April 17, 2026

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness

Conexiant

April 16, 2026

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

Conexiant

April 06, 2026

Masters Athletes Present Unique CV Findings

Joint clinical consensus outlines evaluation and management considerations for arrhythmias, coronary atherosclerosis, aortic dilatation, myocardial fibrosis, and related findings in older competitive athletes.

Conexiant

April 06, 2026

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Conexiant

April 06, 2026

Low DLCO/SB Linked to Faster SSc Progression

Lower gas transfer at baseline was associated with higher unadjusted progression rates and shorter time to transition, though multivariable analysis did not identify independent predictors

Conexiant

April 02, 2026

ACC/AHA Consensus Sets Tricuspid Program Standards

Multisociety document outlines operator, institutional, and registry requirements as transcatheter tricuspid therapies expand

Conexiant

March 31, 2026

Sudden Death Trajectories in HFpEF, HFmrEF

Clinical changes before death overlap across outcomes

Conexiant

March 27, 2026

ACSM Revises Resistance Training Guidance

Synthesized evidence clarifies which training variables enhance strength, hypertrophy, and performance.

Conexiant

December 13, 2024

New Vaccine Prevents Severe RSV Illness

A recent study showed the new vaccine was more than 90% effective in the prevention of hospitalizations and emergency department visits due to RSV among those 60 years old or older.

Conexiant

November 13, 2024

Is COPD Set to Affect 600M Globally?

GOLD 2025 highlights new pathways and advanced COPD therapies like ensifentrine and dupilumab to reduce exacerbations and address emerging COPD phenotypes.

Conexiant